New acetylcholinesterase inhibitors for Alzheimer's disease (Q34244426)

31 July 2017

title

New acetylcholinesterase inhibitors for Alzheimer's disease (English)

1 reference

31 July 2017

0 references

Mona Mehta

1 reference

31 July 2017

Abdu Adem

series ordinal

1 reference

31 July 2017

Marwan Sabbagh

series ordinal

1 reference

31 July 2017

publication date

15 December 2011

1 reference

International journal of Alzheimer's disease

31 July 2017

published in

1 reference

31 July 2017

volume

2012

1 reference

31 July 2017

page(s)

728983

1 reference

Creative Commons Attribution 3.0 Unported

31 July 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyrighted

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

copyrighted

0 references

cites work

A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246720

Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chlo

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246720

Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246720

Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246720

Tacrine derivatives and Alzheimer's disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246720

Targeting Alzheimer's disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246720

Drug development for Alzheimer's disease: where are we now and where are we headed?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246720

Novel 16-substituted bifunctional derivatives of huperzine B: multifunctional cholinesterase inhibitors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246720

Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246720

Contemporary anticholinesterase pharmaceuticals of natural origin and their synthetic analogues for the treatment of Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246720

Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246720

Vitamin E and donepezil for the treatment of mild cognitive impairment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246720

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246720

Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial

6 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F728983

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F728983

Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F728983

Selective cholinesterase inhibitory activities of a new monoterpene diglycoside and other constituents from Nelumbo nucifera stamens

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F728983

Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F728983

New potential AChE inhibitor candidates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F728983

Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F728983

Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F728983

Design, synthesis and evaluation of novel 5,6-dimethoxy-1-oxo-2,3-dihydro-1H-2-indenyl-3,4-substituted phenyl methanone analogues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F728983

Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F728983

Ladostigil prevents age-related glial activation and spatial memory deficits in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F728983

Acetylcholinesterase inhibitory activity of uleine from Himatanthus lancifolius.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246720

Investigation into the in vivo effects of five novel tacrine/ferulic acid and beta-carboline derivatives on scopolamine-induced cognitive impairment in rats using radial maze paradigm

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246720

Donepezil: potential neuroprotective and disease-modifying effects

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22216416

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2012/728983

1 reference

31 July 2017

1 reference

31 July 2017

1 reference